The performance of companies tied to iconic drugs like Viagra presents a complex investment landscape . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the loss of exclusivity in key territories has introduced substantial uncertainty . Investors are now assessing the consequences of gene